Lactoferrin derived peptides: Mechanisms of action and their perspectives as antimicrobial and antitumoral agents

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 6, 2009, Pages 687-695

  Lizzi, Anna Rita ^a   Carnicelli, Veronica ^a   Clarkson, Matilda M ^a   Di Giulio, Antonio ^a   Oratore, Arduino ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Antimicrobial peptides; Lactoferrampin; Lactoferricin B; Lactoferrin

Indexed keywords

KALIOCIN 1; LACTOFERRAMPIN; LACTOFERRICIN; LACTOFERRIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; ANTINEOPLASTIC AGENT;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BODY FLUID; CANCER CELL; CANCER INHIBITION; CYTOTOXICITY; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; NONHUMAN; PROTEIN FUNCTION; PROTEIN STRUCTURE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; MOLECULAR GENETICS; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; ANTINEOPLASTIC AGENTS; HUMANS; LACTOFERRIN; MOLECULAR SEQUENCE DATA;

EID: 69249208619     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709788452757     Document Type: Article

References (77)

1. Hancock, R.E.; Chapple, D.S. Peptide antibiotics. Antimicrob. Agents Chemother., 1999, 43, 1317-23.
2. Bulet, P.; Dimarcq, J-L.; Hetru, C.; Lagueux, M.; Charlet, M.; Hegy, G.; van Dorsselaer, A.; Hoffman, J.A. A novel inducible antibacterial peptide of Drosophila carries an O- glycosylated substitution. J. Biol. Chem., 1993, 268, 14893-7.
3. Mackintosh, J.A.; Veal, D.A.; Beattie, A.J.; Gooley, A.A. Isolation from an ant Myrmecia gulosa of two inducible O-glycosylated proline-rich antibacterial peptides. J. Biol. Chem., 1998, 273, 6139-43.
4. Hancock, R.E. Peptide antibiotics. Lancet, 1997, 349, 418-22.
5. Andersen, J.H.; Jenssen, H.; Sandvik, K.; Gutteberg, T.J. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparin sulphate at the cell surface. J. Med. Virol., 2004, 74, 262-71.
6. De Lucca, A.J.; Walsh, T.J. Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrob. Agents Chemother., 1999, 43, 1-11.
7. Theis, T.; Stahl, U. Antifungal proteins: targets, mechanisms and prospective applications. Cell. Mol. Life Sci., 2004, 61, 437-55.
8. Papo, N.; Shai, Y. Host defense peptides as new weapons in cancer treatment. Cell. Mol. Life Sci., 2005, 62, 784-90.
9. Jerala, R.; Porro, M. The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone assisted protein folding. Curr. Top. Med. Chem., 2004, 4, 1173-84.
10. Matsuzaki, K. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim. Biophys. Acta, 1998, 1376, 391-400.
11. Heller, W.T.; Waring, A.J.; Lehrer, R.I.; Harroun, T.A.; Weiss, T.M.; Yang, L.; Huang, H.W. Membrane thinning effect of the beta-sheet antimicrobial protegrin. Biochemistry, 2000, 39, 139-45.
12. Marassi, F.M.; Opella, S.J.; Juvvadi, P.; Merri¢eld, R.B. Orientation of cecropin A helices in phospholipid bilayers determined by solid-state NMR spectroscopy. Biophys. J., 1999, 77, 3152-55.
13. Gifford, J.L.; Hunter, H.N.; Vogel, H.J. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell. Mol. Life Sci., 2005, 62, 2588-98.
14. Otvos Jr. L.; Rogers, M.E.; Consolvo, P.J.; Condie, B.A.; Lovas, S.; Bulet, P.; Blaszczyk- Thurin, M. Interaction between heat shock proteins and antimicrobial peptides. Biochemistry, 2000, 39, 14150-9.
15. Park, C.B.; Kim, H.S.; Kim, S.C. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun., 1998, 244, 253-7.
16. Patrzykat, A., Friedrich, C.L., Zhang, L., Mendoza, V., Hancock, R.E. Sublethal concentrations of pleurocidinderived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob. Agents Chemother., 2002, 46, 605-14.
17. Subbalakshmi, C; Sitaram, N. Mechanism of antimicrobial action of indolicidin. FEMS Microbiol. Lett., 1998, 160, 91-6.
18. Andreu, D.; Rivas, L. Animal antimicrobial peptides: an overview. Biopolymers, 1998, 47, 415-33.
19. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature, 2002, 415, 389-95.
20. Marr, A.K.; Gooderham, W.J.; Hancock, R.E.W. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacology, 2006, 6, 468-72.
21. Wei, X.; Decker, J.M.; Liu, H.; Zhang, Z.; Arani, R.B.; Kilby, J.M.; Saag, M.S.; Wu, X.; Shaw, G.M.; Kappes, J.C. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) mono therapy Antimicrob. Agents Chemother., 2002, 46, 1896-905.
22. Bowne, W.B.; Michl, J.; Bluth, M.H.; Zenilman, M.E.; Pincus, M.R. Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancer. Cancer Ther., 2007, 5B, 331-44.
23. Nguyen, V.T.; Gidley, M.J.; Dykes, G.A. Potential of a.nisincontaining bacterial cellulose film to inhibit Listeria monocytogenes on processed meats. Food Microbiol. B., 2008, 25, 471-8.
24. Shai, Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta, 1999, 1462, 55-70.
25. Labischinski, H.; Barnickel, G.; Bradaczek. H.; Naumann, D.; Rietschel, E.T.; Giesbrecht, P. High state of order of isolated bacterial lipopolysaccharide and its possible contribution to the permeation barrier property of the outer membrane. J Bacteriol., 1985, 162, 9-20.
26. Powers, J-P.S.; Hancock, R.E.W. The relationship between peptide structure and antibacterial activity. Peptides, 2003, 24, 1681-91.
27. Wimley, W.C.; White, S.H. Experimental determined hydrophobicity scale for proteins at membrane interfaces. Nat. Struct. Biol., 1996, 3, 842-8.
28. Hoshino, A.; Hisayasu, S.; T. Shimada, T. Complete sequence analysis of rat transferrin and expression of transferrin but not lactoferrin in the digestive glands. Comp. Biochem. Physiol. B., 1996, 113, 491-7.
29. Sénchez, L.; Calvo M.; Brock, J.H. Biological role of lactoferrin. Arch. Dis. Child., 1992, 67, 657-61.
30. Baker, E.N.; Baker, H.M. Molecular structure, binding properties and dynamics of lactoferrin. Cell. Mol. Life Sci., 2005, 62, 2531-39.
31. Stumpf, P.; Welch, U. Secretory and defensive functions of the duct system of the lactating mammary gland of the African elephant (Loxodonta africana, Proboscidea). Zoomorphology, 2004, 123, 155-67.
32. Anderson, B.F.; Baker, H.M.; Norris, G.E.; Rice D.W.; Baker E.N. Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 Å resolution J. Mol. Biol., 1989, 209, 711-34.
33. Moore, S.A.; Anderson, B.F.; Groom, C.R.; Haridas M.; Baker, E.N. Three-dimensional structure of diferric bovine lactoferrin at 2.8 Å resolution. J. Mol. Biol., 1997, 274, 222-36
34. Karthikeyan, S.; Paramasivam, M.; Yadav, S.; Srinivasan, R.; Singh, T.P. Structure of buffalo lactoferrin at 2.5 Å resolution using crystals grown at 303 K shows different orientation of the N and C lobes. Acta Crystallogr., 1999, D55, 1805-13.
35. Sharma, A.K.; Paramasivam, M.; Srinivasan, A.; Yadav M.P.; Singh, T.P. Three- dimensional structure of mare diferric lactoferrin at 2.6 Å resolution. J. Mol. Biol., 1998, 289, 303-17.
36. Khan, J.A.; Kumar, P.; Paramasivam, M.; Yadav, R.S.; Sahani, M.S.; Sharma, S.; Srinivasan, A.; Singh,T.P. Camel lactoferrin, a transferrin-cum-lactoferrin: crystal structure of camel apolactoferrin at 2.6 Å resolution and structural basis of its dual role. J. Mol. Biol., 2001, 309, 751-61.
37. +3-binding protein reveals convergent evolution within a superfamily. Nat. Struct. Biol., 1997, 4, 919-24.
38. Zakharova, E.T.; Shavlovski, M.M.; Bass, M.G.; Gridasova, A.A.; Pulina, M.O.; De Filippis, V.; Beltramini, M.; Di Muro, P.; Salvato, B.; Fontana, A.; Vasilyev, V.B.; Gaitskhoki, V.S. Interaction of lactoferrin with ceruloplasmin. Arch. Biochem. Biophys., 2000, 374, 222-8.
39. Levay, P.F.; Viljoen, M. Lactoferrin: a general review. Haematologica, 1995, 80, 252-67.
40. Kuwata, H.; Yip, T-T.; Tomita, M.; Hutchens, T.W. Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin. Biochim. Biophys. Acta, 1998, 1429, 129-41.
41. Tomita, M., Bellamy, W.; Takase, M.; Yamauchi, K.; Wakabayashi, H.; Kawase, K. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J. Dairy Sci., 1991, 74, 4137-42.
42. Bellamy, W.; Takase, M.; Yamauchi, K.; Wakabayashi, H.; Kawase, K.; Tomita, M. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta, 1992, 1121, 130-6.
43. Zhou, N.; Tieleman, D.P.; Vogel, H.J. Molecular dynamics simulations of bovine lactoferricin: turning a helix into a sheet. BioMetal,s 2004, 17, 217-23.
44. Yamauchi, K.; Tomita, M.; Giehl, T.J.; Ellison III, R.T. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect. Immun., 1993, 61, 719-28.
45. Strøm, M.B.; Rekdal, O.; Svendsen, J,S. Antimicrobial activity of short arginine- and tryptophan-rich peptides. J. Pept. Sci,. 2002, 8, 431-7.
46. Haug, B.E., Svedsen, J.S. The role of tryptophan in the antibacterial activity of a 15-residue bovine lactoferricin peptide. J. Pept. Sci., 2001, 7, 190-6.
47. Strøm, M.B.; Rekdal, O.; Svendsen, J.S. Antibacterial activity of 15-residue lactoferricin derivatives. J. Pept. Res., 2000, 56, 265-74.
48. Leveugle, B.; Mazurier, J.; Legrand, D.; Mazurier, C.; Montreuil, J.; Spik, G. Lactotransferrin binding to its platelet receptor inhibits platelet aggregation. Eur. J. Biochem., 1993, 213, 1205-11.
49. Ziere, G. J.; Bijsterbosch, M.K.; Van Berkel, T.J.C. Removal of 14 N-terminal amino acids of lactoferrin enhances its affinity for parenchymal liver cells and potentiates the inhibition of beta- very low density lipoprotein binding. J. Biol. Chem., 1993, 268, 27069-75.
50. Legrand, D.; Mazurier, J.; Elass, A.; Rochard, E.; Vergoten, G.; Maes, P.; Montreuil, J.; Spik, G. Molecular interactions between human lactotransferrin and the phytohemagglutinin- activated human lymphocyte lactotransferrin receptor lie in two loop containing regions of the N-terminal domain I of human lactotransferrin. Biochemistry, 1992, 31, 9243-51.
51. Deber, C.M.; Goto, N.K. Folding proteins into membranes. Nat. Struct. Biol., 1996; 3, 815-8.
52. van der Kraan, M.I., Groenink, J.; Nazmi, K.; Veerman, E.C.; Bolscher, J.G.; Nieuw Amerongen, A.V. Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin. Peptides, 2004, 25, 177-83.
53. Sunilkumar P.N.; Sadasivan, C.; Devaky, K.S.; Haridas, M. Conformation of an octapeptide fragment (2-9) of kaliocin-1 in DMSOd6 by 1H NMR and restrained molecular dynamics. Indian J. Biochem. Biophys., 2007, 44, 44-9.
54. Marieke, I.A.; van der Kraan, A.; van Marle, J.; Nazmi, K.; Groenink, J.; van't Hof, W.; Veerman, E.C.I.; Bolscher, J.G.M. Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli. Peptides, 2005, 26, 1537-42.
55. Takakura, N.; Wakabayashi, H.; Yamauchi, K.; Takase, M. Influences of orally administered lactoferrin on IFN-gamma and IL-10 production by intestinal intraepithelial lymphocytes and mesenteric lymph-node cells. Biochem. Cell Biol., 2006, 84, 363-8.
56. Wang, W.P.; Iigo, M.; Sato, J.; Sekine, K.; Adachi, I.; Tsuda. Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin. Jpn. J. Cancer Res., 2000, 91, 1022-7.
57. Shau, H.; Kim, A.; Golub, S.H. Modulation of natural killer and lymphokine- activated killer cell cytotoxicity by lactoferrin. J. Leukoc. Biol., 1992, 51, 343-9.
58. Manev, V.; Maneva, A.; Sirakov, L. Effect of lactoferrin on the phagocytic activity of polymorphonuclear leucocytes isolated from blood of patients with autoimmune diseases and Staphylococcus aureus allergy. Adv. Exp. Med. Biol., 1998, 443, 321-30.
59. Miyauchi, H.; Hashimoto, S.; Nakajima, M.; Shinoda, I.; Fukuwatari, Y.; Hayasawa, H. Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: identification of its active domain. Cell Immunol., 1998, 187, 34-7.
60. Puddu, P.; Carollo, M.G.; Belardelli, F.; Valenti, P.; Gessani, S.J.. Role of endogenous interferon and LPS in the immunomodulatory effects of bovine lactoferrin in murine peritoneal macrophages. Leukoc. Biol., 2007, 82, 347-53.
61. Okamoto, I.; Kohno, K.; Tanimoto, T.; Ikegami, H.; Kurimoto, M. Development of CD8+T effector T cells is differentially regulated by IL-18 and IL-12. J. Immunol., 1999, 162, 3202-11.
62. Damiens, E.; el Yazidi, I.; Mazurier, J.; Duthille, I.; Spik, G.; Boilly-Marer, Y.J. Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells. Cell Biochem., 1999, 74, 486-98.
63. Wolf, J.S.; Li, G.; Varadhachary, A.; Petrak, K.; Schneyer, M.; Li, D.; Ongkasuwan, J.; Zhang, X.; Taylor, R.J.; Strome, S.E.; O'Malley, B.W. Jr. Oral lactoferrin results in T cell -dependent tumor inhibition of Head and Neck squamous cell carcinoma in vivo. Clin. Cancer Res., 2007, 13, 1601-10.
64. Son, H.J.; Lee, S.H.; Choi, S.Y. Human lactoferrin controls the level of retinoblastoma protein and its activity. Biochem. Cell Biol., 2006, 84, 345-50.
65. Umeyama, M.; Kira, A.; Nishimura, K.; Naito, A. Interactions of bovine lactoferricin with acidic phospholipid bilayers and its antimicrobial activity as studied by solid-state NMR. Biochim. Biophys. Acta, 2006, 1758, 1523-8.
66. Dennis, J.W. N-linked oligosaccharide processing and tumor cell biology. Semin. Cancer Biol., 1991, 2, 411-20.
67. Dobrzynska, J.; Szachowicz-Petelska, B.; Sulkowski, S.; Figaszewski, Z. Changes in electric charge and phospholipids composition in human colorectal cancer cells. Mol. Cell. Biochem., 2005, 276, 113-9.
68. Yoon, W.H.; Park, H.D.; Lim K.; Hwang, B.D. Effect of Oglycosylated mucin on invasion and metastasis of HM7 human colon cancer cells. Biochem. Biophys. Res. Commun., 1996, 222, 694-99.
69. Mader, J.S.; Richardson, A.; Salsman, J.; Top, D.; de Antueno, R.; Duncan, R.; Hoskin.D.W. Bovine lactoferricin causes apoptosis in Jurkat T-leukemia cells by sequential permeabilization of the cell membrane and targeting of mitochondria. Exp. Cell Res., 2007, 313, 2634-50.
70. Mader, J.S.; Salsman, J.; Conrad, D.M.; Hoskin, D.W. Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines. Mol. Cancer Ther., 2005, 4, 612-24.
71. Sakai, T.; Banno, Y.; Kato, Y.; Nozawa, Y.; Kawaguchi, M. Pepsin-digested bovine lactoferrin induces apoptotic cell death with JNK/ SAPK activation in oral cancer cells. J. Pharmacol. Sci., 2005, 98, 41-8.
72. Mader, J.S.; Smyth, D.; Marshall, J.; Hoskin, D.W. Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells. Am. J. Pathol., 2006, 169, 1753- 66.
73. Eliassen LT, Berge G, Leknessund A, Wikman M, Lindin I, Løkke C, Ponthan F, Johnsen JI, Sveinbjörnsson B, Kogner P, Flaegstad T, Rekdal. O. The antimicrobial peptide lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo Int. J. Cancer, 2006, 119, 493-500.
74. Onishi, J.; Roy, M.K.; Juneja, L.R.; Watanabe, Y.; Tamai, Y. A lactoferrin-derived peptide with cationic residues concentrated in a region of its helical structure induces necrotic cell death in a leukemic cell line (HL-60). J. Pept. Sci., 2008, 14, 1032-8.
75. Hunter, H.N.; Demcoe, A.R.; Jenssen, H.; Gutteberg, T.J.; Vogel, H.J. Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent. Antimicrob Agents Chemother., 2005, 49, 3387-95.
76. Wang, G.; Li, Y.; Li, X. Correlation of three-dimensional structures with the antimicrobial activity of a group of peptides designed based on a nontoxic bacterial membrane anchor. The J. Biol. Chem., 2005, 280, 5803-5811.
77. Haney, E.F.; Nazmi, K.; Lau, F.; Bolscher, J.G.; Vogel, H.J. Novel lactoferrampin antimicrobial peptides derived from human lactoferrin. Biochimie, 2009, 91, 141-54.